Clinical trial
Evaluation of the Relationship Between Hyperemesis Gravidarum (HEG) With Platelet Crit (PCT), Haemoglobin to Red Cell Distribution Width Ratio (HRR) and Neutrophil to Lymphocyte Ratio (NLR).
NCT06245811 is registered in ClinicalTrials.gov with Izzet Celegen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Relationship Between Hyperemesis Gravidarum (HEG) With Platelet Crit (PCT), Haemoglobin to Red Cell Distribution Width Ratio (HRR) and Neutrophil to Lymphocyte Ratio (NLR).
- Lead sponsor
- Izzet Celegen
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 20, 2022
- Completion date
- June 20, 2022
- Enrollment
- 215 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.